Clinical Welfare
Public Welfare
Clinical Apply
News
New Release
Infectious disease
Hematology / Oncology
NonInfectious disease
Male Health
Palbociclib (Palbociclib) is a drug for the treatment of ER-positive and HER2-negative advanced or metastatic breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.